DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Bhat V, von Drygalski A, Gale AJ, Griffin JH, Mosnier LO.
Synergistic effect in bleed reduction by superFVa and recombinant human FVIIa in vivo suggest a novel bypassing strategy for hemophilia patients with inhibitors.
Blood 2014;
14 (Suppl): 692 (abstract)
We do not assume any responsibility for the contents of the web pages of other providers.